{
  "condition": "tuberculosis",
  "name": "Tuberculosis (TB)",
  "category": "infectious_disease",
  "prevalence": "high",
  "description": "Bacterial infection primarily affecting the lungs, caused by Mycobacterium tuberculosis",
  
  "symptoms": {
    "primary": [
      {
        "name": "persistent_cough",
        "weight": 0.9,
        "description": "Cough lasting more than 2-3 weeks",
        "duration": "> 3 weeks"
      },
      {
        "name": "coughing_blood",
        "weight": 0.95,
        "description": "Hemoptysis - coughing up blood or blood-stained sputum",
        "severity": "high"
      },
      {
        "name": "weight_loss",
        "weight": 0.8,
        "description": "Unexplained weight loss over weeks/months",
        "pattern": "gradual"
      },
      {
        "name": "night_sweats",
        "weight": 0.7,
        "description": "Profuse sweating during sleep",
        "frequency": "regular"
      },
      {
        "name": "fever",
        "weight": 0.6,
        "description": "Low-grade fever, often in evenings",
        "pattern": "intermittent"
      }
    ],
    "secondary": [
      {
        "name": "fatigue",
        "weight": 0.5,
        "description": "Persistent tiredness and weakness"
      },
      {
        "name": "loss_of_appetite",
        "weight": 0.4,
        "description": "Reduced desire to eat"
      },
      {
        "name": "chest_pain",
        "weight": 0.4,
        "description": "Pain in chest, especially when breathing or coughing"
      }
    ]
  },

  "risk_factors": [
    {
      "factor": "hiv_infection",
      "weight": 0.8,
      "description": "HIV co-infection significantly increases TB risk"
    },
    {
      "factor": "malnutrition",
      "weight": 0.6,
      "description": "Poor nutritional status"
    },
    {
      "factor": "overcrowding",
      "weight": 0.4,
      "description": "Living in crowded conditions"
    },
    {
      "factor": "smoking",
      "weight": 0.3,
      "description": "Tobacco use"
    },
    {
      "factor": "diabetes",
      "weight": 0.3,
      "description": "Diabetes mellitus"
    }
  ],

  "diagnostic_criteria": {
    "clinical": [
      "Persistent cough > 2 weeks",
      "Weight loss",
      "Night sweats",
      "Fever"
    ],
    "investigations": [
      "Sputum microscopy for AFB",
      "Chest X-ray",
      "GeneXpert MTB/RIF",
      "Tuberculin skin test (TST)"
    ]
  },

  "treatment": {
    "first_line": {
      "intensive_phase": {
        "duration": "2 months",
        "drugs": [
          {
            "medication": "Isoniazid (H)",
            "dosage": "5mg/kg daily (max 300mg)",
            "administration": "oral"
          },
          {
            "medication": "Rifampin (R)",
            "dosage": "10mg/kg daily (max 600mg)",
            "administration": "oral"
          },
          {
            "medication": "Ethambutol (E)",
            "dosage": "15mg/kg daily (max 1200mg)",
            "administration": "oral"
          },
          {
            "medication": "Pyrazinamide (Z)",
            "dosage": "25mg/kg daily (max 2000mg)",
            "administration": "oral"
          }
        ]
      },
      "continuation_phase": {
        "duration": "4 months",
        "drugs": [
          {
            "medication": "Isoniazid (H)",
            "dosage": "5mg/kg daily (max 300mg)",
            "administration": "oral"
          },
          {
            "medication": "Rifampin (R)",
            "dosage": "10mg/kg daily (max 600mg)",
            "administration": "oral"
          }
        ]
      }
    },
    "supportive_care": [
      "Nutritional support and counseling",
      "HIV testing and treatment if positive",
      "Contact tracing and screening",
      "Directly Observed Treatment (DOT)",
      "Regular monitoring for side effects"
    ],
    "monitoring": [
      "Monthly clinical assessment",
      "Sputum examination at 2, 5, and 6 months",
      "Liver function tests if indicated",
      "Visual acuity monitoring (ethambutol)"
    ]
  },

  "complications": [
    {
      "name": "drug_resistance",
      "description": "MDR-TB or XDR-TB",
      "management": "Specialized treatment regimen"
    },
    {
      "name": "pleural_effusion",
      "description": "Fluid accumulation in pleural space",
      "management": "Drainage if large"
    },
    {
      "name": "miliary_tb",
      "description": "Disseminated tuberculosis",
      "management": "Intensive treatment"
    }
  ],

  "prevention": [
    "BCG vaccination in endemic areas",
    "Infection control measures",
    "Contact screening",
    "Isoniazid preventive therapy for high-risk contacts",
    "HIV prevention and treatment"
  ],

  "danger_signs": [
    "coughing_blood",
    "severe_weight_loss",
    "difficulty_breathing",
    "altered_consciousness",
    "severe_chest_pain"
  ],

  "follow_up": {
    "frequency": "monthly",
    "duration": "6 months minimum",
    "assessments": [
      "Clinical improvement",
      "Weight gain",
      "Sputum conversion",
      "Treatment adherence",
      "Side effects monitoring"
    ]
  },

  "special_populations": {
    "hiv_coinfection": {
      "considerations": [
        "Higher risk of treatment failure",
        "Drug interactions with ARVs",
        "Immune reconstitution syndrome",
        "Extended treatment duration may be needed"
      ]
    },
    "pregnancy": {
      "safe_drugs": ["Isoniazid", "Rifampin", "Ethambutol"],
      "avoid": ["Streptomycin"],
      "monitoring": "Enhanced fetal monitoring"
    },
    "children": {
      "dosing": "Weight-based dosing",
      "formulations": "Child-friendly formulations preferred",
      "monitoring": "Growth and development"
    }
  }
}